Purpose
Total pelvic exenteration is performed infrequently in selected patients with locally advanced or recurrent colorectal cancer. We reviewed our contemporary experience with pelvic exenteration for colorectal cancer to identify selection criteria and prognostic factors for longterm survival. METHODS: Between 1991 and 2000, 55 patients (males, 29; median age, 62 years) undergoing total pelvic exenteration for colorectal cancer were identified from a prospective database. Clinicopathologic variables were evaluated as prognostic indicators of long-term survival by log-rank test and multivariate Cox regression. RESULTS: Indications for surgery were recurrent colorectal cancer in 71 percent and primary colorectal cancer in 29 percent. Of 39 patients with recurrent colorectal cancer, 85 percent had previous radiotherapy, and 64 percent had previous abdominoperineal resection. At the time of pelvic exenteration, 49 percent of patients received intraoperative radiation, and 20 percent required sacrectomy. Complete resection with negative margins was achieved in 73 percent. Perioperative mortality after pelvic exenteration was 5.5 percent, and complications included perineal wound infection (40 percent), pelvic abscess (20 percent), abdominal wound infection (18 percent), and cardiopulmonary events (18 percent). Median disease-specific survival for all patients was 48.9 (range, 3.2-105.6) months. Univariate analysis identified five factors associated with decreased survival: male gender, recurrent colorectal cancer, previous abdominoperineal resection, positive surgical margin, and administration of intraoperative radiation. On multivariate analysis, only previous abdominoperineal resection was an independent predictor of unfavorable outcome (P < 0.04). CONCLUSIONS: Total pelvic exenteration can be performed safely in highly selected patients with colorectal cancer and can result in significantly prolonged survival. Less satisfactory outcomes are observed in patients whose indication for pelvic exenteration is recurrent colorectal cancer after abdominoperineal resection.
Similar content being viewed by others
References
Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma. Cancer 1948;l:177–83
Boey J, Wong J, Ong GB. Pelvic exenteration for locally advanced colorectal carcinoma. Ann Surg 1982;195:513–8.
Chen HS, Sheen-Chen SM. Total pelvic exenteration for primary local advanced colorectal cancer. World J Surg 2001;25:1546–9.
Hida J, Yasutomi M, Maruyama T,et al. Results from pelvic exenteration for locally advanced colorectal cancer with lymph node metastases. Dis Colon Rectum 1998;4l:l65–8.
Law WL, Chu KW, Choi HK. Total pelvic exenteration for locally advanced rectal cancer. J Am Coll Surg 2000; 190:78–83.
Ledesma EJ, Bruno S, Mittelman A. Total pelvic exenteration in colorectal disease: a 20-year experience. Ann Surg 1981; 194:701–3.
Lopez MJ, Kraybill WG, Downey RS, Johnston WD, Bricker EM. Exenterative surgery for locally advanced rectosigmoid cancers. Is it worthwhile. Surgery 1987; 102:644–51.
Shirouzu K, Isomoto H, Kakegawa T. Total pelvic exenteration for locally advanced colorectal carcinoma. Br J Surg 1996;83:32–5.
Morrow CP, Curtin JP. Reconstructive surgery. In: Morrow CP, Curtin JP, eds. Gynecologic cancer surgery. New York: Churchill Livingstone, 1996:323–80.
Copeland LJ, Hancock KC, Gershenson DM, Stringer CA, Atkinson EN, Edwards CL. Gracilis myocutaneous vaginal reconstruction concurrent with total pelvic exenteration. Am J Obstet Gynecol 1989;l60:1095–101.
Wong WD, Jensen LL, Bartolo DC, Rothenberger DA. Artificial anal sphincter. Dis Colon Rectum 1996; 39:1345–51.
Husain A, Curtin J, Brown C,et al. Continent urinary diversion and low-rectal anastomosis in patients under-going exenterative procedures for recurrent gyneco-logic malignancies. Gynecol Oncol 2000;78:208-ll.
Jurado M, Bazan A, Elejabeitia J, Paloma V, Martinez- Monge R, Alcazar JL. Primary vaginal and pelvic floor reconstruction at the time of pelvic exenteration: a study of morbidity. Gynecol Oncol 2000;77:293–7.
Skinner DG, Sherrod A. Total pelvic exenteration with simultaneous bowel and urinary reconstruction. J Urol 1990; 144:1433–9.
American Joint Committee on Cancer. AJCC cancer staging manual. Philadelphia: Lippincott-Raven, 1997.
Brintnall ES, Flocks RH. En masse pelvic viscerectomy with ureterointestinal anastomosis. Arch Surg 1950;6l:851–64.
Hafner GH, Herrera L, Petrelli NJ. Morbidity and mortality after pelvic exenteration for colorectal adenocarcinoma. Ann Surg 1992;215:63–7.
Chi DS, Gemignani ML, Curtin JP, Hoskins WJ. Longterm experience in the surgical management of cancer of the uterine cervix. Semin Surg Oncol 1999;17:l6l-7.
Salo JC, Paty PB, Guillem J, Minsky BD, Harrison LB, Cohen AM. Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience. Ann Surg Oncol 1999;6:171–7.
Author information
Authors and Affiliations
About this article
Cite this article
Jimenez, R.E., Shoup, M., Cohen, A.M. et al. Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer. Dis Colon Rectum 46, 1619–1625 (2003). https://doi.org/10.1007/BF02660766
Issue Date:
DOI: https://doi.org/10.1007/BF02660766